Studies on the neuropharmacology of papaverine. II. The effect on neuromuscular transmission in the whole animal.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D003650:Decamethonium Compounds / Q000494:pharmacology; D003864:Depression, Chemical; D004347:Drug Interactions; D004357:Drug Synergism; D004558:Electric Stimulation; D004837:Epinephrine / Q000494:pharmacology; D007271:Injections, Intradermal; D009119:Muscle Contraction / Q000187:drug effects*; D009132:Muscles / Q000187:drug effects; D009388:Neostigmine / Q000494:pharmacology; D010208:Papaverine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects; D012584:Sciatic Nerve / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects*; D013997:Time Factors; D014403:Tubocurarine / Q000494:pharmacology
D003650:Decamethonium Compounds; D009388:Neostigmine; D011433:Propranolol; D010208:Papaverine; D014403:Tubocurarine; D004837:Epinephrine; D010646:Phentolamine